Nuveen Asset Management, LLC Incyte Corp Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 485,868 shares of INCY stock, worth $34.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

485,868

Previous 461,684 5.24%

Holding current value

$34.8 Million

Previous $28 Million 14.75%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $1.39 Million - $1.66 Million	24,184 Added 5.24%	485,868 $32.1 Million
Q2 2024 Aug 09, 2024	SELL	$51.18 - $63.75 $1.46 Million - $1.82 Million	-28,577 Reduced 5.83%	461,684 $28 Million
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $6,899 - $8,123	122 Added 0.02%	490,261 $27.9 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $1.23 Million - $1.52 Million	-23,624 Reduced 4.6%	490,139 $30.8 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $1.11 Million - $1.27 Million	19,284 Added 3.9%	513,763 $29.7 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $66,862 - $82,834	-1,097 Reduced 0.22%	494,479 $30.8 Million
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $452,983 - $554,764	-6,450 Reduced 1.28%	495,576 $35.8 Million
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $1.42 Million - $1.77 Million	-21,084 Reduced 4.03%	502,026 $40.3 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $479,010 - $599,740	-7,238 Reduced 1.36%	523,110 $34.9 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $84,776 - $106,553	-1,281 Reduced 0.24%	530,348 $40.3 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $47,534 - $57,391	-720 Reduced 0.14%	531,629 $40.7 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $3.19 Million - $3.73 Million	-50,312 Reduced 8.63%	532,349 $39.1 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $10.8 Million - $13.2 Million	-156,766 Reduced 21.2%	582,661 $40.1 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $9.59 Million - $10.5 Million	-120,029 Reduced 13.97%	739,427 $62.2 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $2.82 Million - $3.73 Million	-37,130 Reduced 4.14%	859,456 $69.8 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $18.1 Million - $21.9 Million	224,602 Added 33.42%	896,586 $78 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $14 Million - $18.1 Million	-164,739 Reduced 19.69%	671,984 $60.3 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $26.5 Million - $38.9 Million	-357,522 Reduced 29.94%	836,723 $87 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $10.1 Million - $13.7 Million	159,445 Added 15.41%	1,194,245 $0
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $4.66 Million - $6.1 Million	-63,740 Reduced 5.8%	1,034,800 $90.4 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $81.1 Million - $96.4 Million	-1,114,182 Reduced 50.35%	1,098,540 $81.5 Million
Q2 2019 Aug 15, 2019	BUY	$73.52 - $88.7 $158 Million - $191 Million	2,149,784 Added 3415.72%	2,212,722 $188 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $4 Million - $5.55 Million	62,938 New	62,938 $5.41 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $11.9 Million - $14.8 Million	-127,004 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $13.9 Million - $17.6 Million	127,004	127,004 $14.8 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Incyte Corp Transaction History